Coffey-Holden Prostate Cancer Academy 2018
The 6th annual Coffey-Holden Prostate Cancer Academy took place at UCLA from June 21st - 24th. This annual, invitation-only meeting sponsored by the Prostate Cancer Foundation is uniquely designed to...Read More
How Your Spit May Help Doctors Diagnose Prostate Cancer
Original article issued by Healthline. It might seem inconceivable that a simple saliva test can tell you your chances of developing cancer. But evidently it can. And the reason is crude...Read More
Researchers find prostate cancer drug byproduct can fuel cancer cells
Original press release issued by: Cleveland Clinic. A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to...Read More
Crystal Ball for Predicting Cancer Treatment Response: Your Poop?
What does the population of bacteria in your gut (called the gut “microbiome”) have to do with prostate cancer? Just how important is this gut flora, or bacteria, anyway? It’s...Read More
Len Bellavia is “Cruisin’ For the Cure” Again
Back in January, we shared Len Bellavia’s story about his “new lease on life” after a mistaken diagnosis of advanced prostate cancer - what he called “the worst moment of...Read More
For Your Daughter
https://vimeo.com/740911737/1b5c603e4c This Father’s Day, if you won’t do it for yourself, do it for your daughter. Dr. Mary-Claire King, a geneticist at the University of Washington, who is credited with...Read More
New Study Identifies Another Opportunity for Precision Immunotherapy in Prostate Cancer
A new Prostate Cancer Foundation (PCF)-funded study published today in the scientific journal Cell has identified a new subtype of advanced prostate cancer – one which may be treatable with...Read More
Non-coding DNA reveals a route by which advanced prostate cancer resists treatment
More than three quarters of metastatic prostate cancers that resist hormone-blocking therapies may harbor several duplicates of both the gene for a treatment resistance factor called the androgen receptor (AR)...Read More
Reflecting on 1,000 miles
Steve Malikowski, who has been diagnosed with metastatic prostate cancer, set out to cross the country on a bike in early May. It’s a total of 4,100 miles from coast...Read More
New and More Sensitive Prostate Cancer Imaging on the Near Horizon
At the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, promising results were reported from a phase 2/3 clinical trial testing the accuracy of a new prostate cancer imaging...Read More
- 1
- 2